Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Other Operating Expenses for 7 consecutive years, with -$17.2 million as the latest value for Q2 2025.

  • Quarterly Other Operating Expenses changed N/A to -$17.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$17.7 million through Jun 2025, down 16317.59% year-over-year, with the annual reading at -$108000.0 for FY2024, N/A changed from the prior year.
  • Other Operating Expenses hit -$17.2 million in Q2 2025 for Benitec Biopharma, down from -$5.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.1 million in Q4 2024 to a low of -$17.2 million in Q2 2025.
  • Historically, Other Operating Expenses has averaged -$2.0 million across 5 years, with a median of $1000.0 in 2021.
  • Biggest five-year swings in Other Operating Expenses: surged 507100.0% in 2024 and later tumbled 185100.0% in 2025.
  • Year by year, Other Operating Expenses stood at $1000.0 in 2021, then surged by 800.0% to $9000.0 in 2022, then tumbled by 88.89% to $1000.0 in 2023, then soared by 507100.0% to $5.1 million in 2024, then tumbled by 440.04% to -$17.2 million in 2025.
  • Business Quant data shows Other Operating Expenses for BNTC at -$17.2 million in Q2 2025, -$5.6 million in Q1 2025, and $5.1 million in Q4 2024.